Human TRIM5α mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants

Retrovirology

Volumn 3, Issue , 2006, Pages

  Kaumanns, Patrick ^a   Hagmann, Isabel ^a   Dittmar, Matthias T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOPLASM PROTEIN; PROTEIN LV2; PROTEIN TRIM5 ALPHA; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; CARRIER PROTEIN; G PROTEIN, VESICULAR STOMATITIS VIRUS; MEMBRANE PROTEIN; TRIM5 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PROTEIN EXPRESSION; VESICULAR STOMATITIS VIRUS; VIRUS CAPSID; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS PARTICLE; VIRUS TYPING; WILD TYPE; CELL LINE; CLASSIFICATION; GENETICS; HELA CELL; MEMBRANE FUSION; METABOLISM; PATHOGENICITY; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MIRIDAE; VESICULAR STOMATITIS VIRUS;

CAPSID; CARRIER PROTEINS; CELL LINE; GENE PRODUCTS, ENV; HELA CELLS; HIV-1; HIV-2; HUMANS; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 33750996702     PISSN: 17424690     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-3-79     Document Type: Article

References (25)

1. Lee K, KewalRamani VN: In defense of the cell: TRIM5alpha interception of mammalian retroviruses. Proc Natl Acad Sci USA 2004, 101:10496-10497.
2. Goff SP: Retrovirus restriction factors. Mol Cell 2004, 16:849-859.
3. Hatziioannou T, Perez-Caballero D, Cowan S, Bieniasz PD: Cyclophilin interactions with incoming human immunodeficiency virus type I capsids with opposing effects on infectivity in human cells. J Virol 2005, 79:176-183.
4. Nakayama EE, Miyoshi H, Nagai Y, Shioda T: A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J Virol 2005, 79:8870-8877.
5. Perron MJ, Stremlau M, Song B, Ulm W, Mulligan RC, Sodroski J: TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci USA 2004, 101:11827-11832.
6. Song B, Javanbakht H, Perron M, Park do H, Stremlau M, Sodroski J: Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J Virol 2005, 79:3930-3937.
7. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
8. Stremlau M, Perron M, Welikala S, Sodroski J: Species-specific variation in the 830.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol 2005, 79:3139-3145.
9. Ylinen LM, Keckesova Z, Wilson SJ, Ranasinghe S, Towers GJ: Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J Virol 2005, 79:11580-11587.
10. McKnight A, Griffiths DJ, Dittmar M, Clapham P, Thomas E: Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2. J Virol 2001, 75:6914-6922.
11. Schmitz C, Marchant D, Neil SJ, Aubin K, Reuter S, Dittmar MT, McKnight A: Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J Virol 2004, 78:2006-2016.
12. Marchant D, Neil SJ, Aubin K, Schmitz C, McKnight A: An envelope-determined, pH-independent endocytic route of viral entry determines the susceptibility of human immunodeficiency virus type I (HIV-1) and HIV-2 to Lv2 restriction. J Virol 2005, 79:9410-9418.
13. Berthoux L, Sebastian S, Sokolskaja E, Luban J: Lv1 inhibition of human immunodeficiency virus type I is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J Virol 2004, 78:11739-11750.
14. Owens CM, Song B, Perron MJ, Yang PC, Stremlau M, Sodroski J: Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type I capsid. J Virol 2004, 78:5423-5437.
15. Shi J, Aiken C: Saturation of TRIM5alpha-mediated restriction of HIV-1 infection depends on thestability of the incoming viral capsid. Virology 2006, 17:17.
16. Hatziioannou T, Cowan S, Goff SP, Bieniasz PD, Towers GJ: Restriction of multiple divergent retroviruses by Lv1 and Ref1. Embo J 2003, 22:385-394.
17. Besnier C, Takeuchi Y, Towers G: Restriction of lentivirus in monkeys. Proc Natl Acad Sci USA 2002, 99:11920-11925.
18. Kootstra NA, Munk C, Tonnu N, Landau NR, Verma IM: Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci USA 2003, 100:1298-1303.
19. Munk C, Brandt SM, Lucero G, Landau NR: A dominant block to HIV-1 replication at reverse transcription in simian cells. Proc Natl Acad Sci USA 2002, 99:13843-13848.
20. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu Y, Shaw GM, Kappes JC: Emergence of resistant human immunodeficiency Virus type I in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002, 46:1896-1905.
21. Hatziioannou T, Perez-Caballero D, Yang A, Cowan S, Bieniasz PD: Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci USA 2004, 101:10774-10779.
22. Reuter S, Kaumanns P, Buschhorn SB, Dittmar MT: Role of HIV-2 envelope in Lv2-mediated restriction. Virology 2005, 332:347-358.
23. Dittmar MT, Zekeng L, Kaptue L, Eberle J, Krausslich HG,, Gurtler L: Coreceptor requirements of primary HIV type I group O isolates from Cameroon. AIDS Res Hum Retroviruses 1999, 15:707-712.
24. Tebit DM, Zekeng L, Kaptue L, Gurtler L, Fackler OT, Keppler OT, Herchenroder O, Krausslich HG: Construction and characterization of an HIV-1 group O infectious molecular clone and analysis of vpr- and nef-negative derivatives. Virology 2004, 326:329-339.
25. Tebit DM, Zekeng L, Kaptue L, Krausslich HG, Herchenroder O: Construction and characterisation of a full-length infectious molecular clone from a fast replicating, X4-tropic HIV-1 CRF02.AG primary isolate. Virology 2003, 313:645-652.